Sri Sai Nikitha Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 29-06-2024
- Paid Up Capital ₹ 0.20 M
as on 29-06-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 8.00 M
as on 29-06-2024
- Revenue %
(FY 2020)
- Profit 98.16%
(FY 2020)
- Ebitda 99.07%
(FY 2020)
- Net Worth -15.76%
(FY 2020)
- Total Assets -45.29%
(FY 2020)
About Sri Sai Nikitha Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.20 M.
The company has closed loans amounting to ₹8.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kalpana Beeravolu, Ramachandra Beeravolu, and Desireddy Venkata serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC054116
- Company No.
054116
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2007
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Sai Nikitha Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpana Beeravolu  | Director | 24-May-2007 | Current |
| Ramachandra Beeravolu | Whole-Time Director | 10-Apr-2008 | Current |
| Desireddy Venkata | Whole-Time Director | 10-Apr-2008 | Current |
Financial Performance of Sri Sai Nikitha Pharma.
Sri Sai Nikitha Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 98.16% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Sai Nikitha Pharma?
In 2018, Sri Sai Nikitha Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 10 Jun 2009 | ₹8.00 M | Satisfied |
How Many Employees Work at Sri Sai Nikitha Pharma?
Unlock and access historical data on people associated with Sri Sai Nikitha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Sai Nikitha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Sai Nikitha Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
